Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002077950-25-000004
Filing Date
2025-09-16
Accepted
2025-09-16 18:07:05
Documents
1
Period of Report
2025-09-12

Document Format Files

Seq Description Document Type Size
1 form3-09162025_100901.html 3  
1 form3-09162025_100901.xml 3 3459
  Complete submission text file 0002077950-25-000004.txt   5161
Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Issuer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH CT 06830 203-409-0812
Deep Track Special Opportunities Fund, LP (Reporting) CIK: 0002077950 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-42831 | Film No.: 251318301